TD-0212 TFA
Modify Date: 2025-08-22 14:50:50
TD-0212 TFA structure
|
Common Name | TD-0212 TFA | ||
|---|---|---|---|---|
| CAS Number | 1073549-11-7 | Molecular Weight | 641.67 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C30H35F4N3O6S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TD-0212 TFATD-0212 TFA is an orally active dual pharmacology angiotensin II type 1 receptor (AT1) antagonist and neprilysin (NEP) inhibitor, with a pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP[1]. |
| Name | TD-0212 TFA |
|---|
| Description | TD-0212 TFA is an orally active dual pharmacology angiotensin II type 1 receptor (AT1) antagonist and neprilysin (NEP) inhibitor, with a pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP[1]. |
|---|---|
| Related Catalog | |
| Target |
pKi: 8.9 (AT1) .pIC50: 9.2 (NEP)[1]. |
| In Vitro | TD-0212 provides the enhanced activity of dual AT1/NEP inhibition with a potentially lower risk of angioedema relative to dual ACE/NEP inhibition[1]. |
| In Vivo | TD-0212 produces blood pressure reductions similar to omapatrilat and combinations of AT1 receptor antagonists and NEP inhibitors in models of renin-dependent and -independent hypertension[1]. |
| References |
| Molecular Formula | C30H35F4N3O6S |
|---|---|
| Molecular Weight | 641.67 |